ESMO AIA

Advocacy in Action at ESMO 2012 Congress in Vienna
Dec
18
2012

Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in Action®, bringing together the influential leaders of the cancer advocacy community to address Personalized Medicine: What it means, its relevance for patients, future research perspectives, collection of tissue specimens, and the role of advocates in shaping public policy […]

Read More
Advocacy in Action ESMO 2012: Cancer and the Media
Dec
18
2012

Selma Schimmel (Vital Options International), Kathy Redmond (Editor, Cancer World Magazine), Jola Gore Booth (EuropaColon) and Fortunato Ciardiello (Chair, ESMO Personalized Medicine Working Group) discuss the media and cancer reporting. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy In Action®, bringing together the influential leaders of the […]

Read More
Advocacy in Action ESMO 2012: Advocate Perspectives in Tissue Collection and Research
Dec
18
2012

Selma Schimmel (Vital Options International), Kathy Oliver (International Brain Tumor Alliance), Francesco De Lorenzo (European Cancer Patient Coalition), Jola Gore Booth (EuropaColon) and Fortunato Ciardiello (Chair, ESMO Personalized Medicine Working Group) discuss tissue collection in cancer research. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy In Action®, […]

Read More
Advocacy in Action ESMO 2012: Personalized Medicine and Pathology
Dec
18
2012

Angelo Paolo Dei Tos, MD (Molecular Pathologist, General Hospital in Treviso, Italy), Selma Schimmel (Vital Options International) and Stefania Vallone (Women Against Lung Cancer Europe – WALCE) discuss pathology and personalized medicine. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in Action®, bringing together the influential leaders […]

Read More
Advocacy in Action ESMO 2012: The Challenges Of Genetic Marker Testing Requirements
Dec
18
2012

Kathy Oliver (International Brain Tumor Alliance), Angelo Paolo Dei Tos, MD (Molecular Pathologist, General Hospital in Treviso, Italy) and Fortunato Ciardiello (Chair, ESMO Personalized Medicine Working Group) discuss the challenges of the genetic marker testing requirements for patients. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in […]

Read More
Advocacy in Action ESMO 2012: What Is the Future Of Personalized Cancer Medicine In Europe?
Dec
18
2012

Ian Banks (Chair of the ECCO Patient Advisory Committee) talks about the futire of personalized cancer medicine in Europe. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in Action®, bringing together the influential leaders of the cancer advocacy community to address Personalized Medicine:  What it means, its […]

Read More
Advocacy in Action ESMO 2012: Key Policy Issues In Personalized Medicine
Dec
18
2012

Francesco De Lorenzo (European Cancer Patient Coalition) talks about the key policy issues around personalized medicine. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in Action®, bringing together the influential leaders of the cancer advocacy community to address Personalized Medicine:  What it means, its relevance for patients, […]

Read More
Advocacy in Action ESMO 2012: Personalized Medicine and Patient Education
Dec
18
2012

Lorenz Jost (Chair, ESMO Patient Working Group) talks about personalized medicine and the importance of educating patients on the topic. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in Action®, bringing together the influential leaders of the cancer advocacy community to address Personalized Medicine:  What it means, […]

Read More
Advocacy in Action ESMO 2012: What Is Personalized Medicine?
Dec
18
2012

Fortunato Ciardiello (Chair, ESMO Personalized Medicine Working Group) introduces personalized medicine. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in Action®, bringing together the influential leaders of the cancer advocacy community to address Personalized Medicine:  What it means, its relevance for patients, future research perspectives, collection of  […]

Read More
A Guide For Patients with Advanced Cancer
Oct
28
2011

Vital Options presents Advocacy in Action (AIA), in partnership with the ESMO Cancer Patient Working Group and in collaboration with the ECCO Patient Advisory Committee. This six-part AIA Forum brings together influential leaders in cancer advocacy, to address the core issues that impact cancer survivorship. Joining Vital Options CEO, Selma Schimmel, will be AIA co-chair […]

Read More